JF26-89 Veterinary Drugs

Utah's Division of Purchasing is announcing its intent to award a sole-source contract for veterinary drugs to Wedgewood Pharmacy without engaging in a standard competitive procurement process, with a notice-and-contest period closing June 24, 2026. The procurement is for the DNR Division of Wildlife Resources.

The contract covers custom-compounded wildlife immobilization pharmaceuticals in specific drug combinations and concentrations — including Xylazine 300 mg/mL, Ketamine 200 mg/mL, Thiafentanil, and Etorphine — that the conducting procurement unit asserts cannot be sourced from any other compounding pharmacy in the United States. The justification rests on Section A of Utah's sole-source exception authority: only one source exists for the procurement item. Market research supports that Wedgewood Pharmacy is the sole provider capable of filling the required prescriptions. The conducting procurement unit notes that modifying specifications to allow competition would compromise the accuracy of remote drug delivery due to the requirement for smaller drug volumes in the custom formulations.

The estimated contract value is $27,224 with no freight costs. Interested vendors may contest the sole-source designation by submitting documentation of competing sources or comparable procurement items that meet or exceed the specified requirements directly to the Division of Purchasing by the June 24 deadline. Vendors must not contact the conducting procurement unit. If no valid contests are received, the Division of Purchasing may execute the contract with Wedgewood Pharmacy without further procurement action.